Galderma Proposes Dividend Hike and Board Shake-Up Amid L’Oréal Influence
Event summary
- Galderma proposes a dividend of 0.35 CHF per share following record 2025 performance.
- Two EQT-backed board members (Michael Bauer, Marcus Brennecke) will step down at the 2026 AGM.
- L’Oréal nominates Delphine Viguier-Hovasse and Samuel du Retail for board seats.
- Harry Kirsch, former Novartis CFO, proposed as new independent board member.
The big picture
Galderma’s board reshuffle reflects L’Oréal’s deepening involvement, aligning with broader trends of strategic realignment in dermatology-focused firms. The dividend proposal underscores strong 2025 results but raises questions about long-term capital allocation amid shifting governance structures.
What we're watching
- Governance Dynamics
- How L’Oréal’s increased influence will shape Galderma’s strategic direction.
- Financial Performance
- Whether the dividend hike signals sustained profitability or aggressive capital return.
- Leadership Transition
- The impact of Harry Kirsch’s expertise on Galderma’s financial strategy and investor confidence.